文献速递衰弱、肌少症与跌倒老年综合评估

FRAIL量表定义的衰弱可预测死亡率:系统综述与荟萃分析

Frailty Defined by FRAIL Scale as a Predictor of Mortality: A Systematic Review and Meta-analysis.
PubMed 文献 · J Am Med Dir Assoc · 2018-01-01

该系统综述与荟萃分析基于8项前瞻性队列研究,评估FRAIL量表定义的衰弱与社区中老年人死亡风险的关系。随机效应荟萃分析纳入3项提供调整风险比的研究,显示衰弱与衰弱前期均显著增加死亡风险。

要点

  • 衰弱者死亡风险显著高于健壮者,合并HR=3.53(95%CI 1.66-7.49,P=.001)。
  • 衰弱前期者死亡风险亦显著增高,合并HR=1.75(95%CI 1.14-2.70,P=.01)。
  • FRAIL量表可有效识别衰弱/衰弱前期并按等级量化死亡风险。

核心结论

  • FRAIL量表能有效识别衰弱/衰弱前期状态,并按等级量化其与死亡风险的关联。

研究设计与样本

  • 系统综述与荟萃分析,纳入8项前瞻性队列研究,对象为社区居住的中老年人。
  • 2018年3月系统检索Embase、Scopus、MEDLINE、CINAHL和PsycINFO,并追踪参考文献与引文。

主要发现

  • 4项研究计算ROC曲线下面积,范围为0.54至0.70。
  • 随机效应荟萃分析纳入3项提供调整HR的研究,比较健壮、衰弱前期和衰弱三组。
  • 衰弱组死亡风险显著高于健壮组,合并HR=3.53(95%CI 1.66-7.49,P=.001)。
  • 衰弱前期组死亡风险亦显著高于健壮组,合并HR=1.75(95%CI 1.14-2.70,P=.01)。
  • 未观察到发表偏倚。

关键数值与推荐

  • 衰弱定义采用FRAIL量表,分组为健壮、衰弱前期和衰弱。
  • 合并HR来自3项研究的调整风险比,采用随机效应模型。

临床怎么用

  • 可将FRAIL量表用于社区中老年人衰弱的识别与分级,辅助死亡风险分层。
  • 对衰弱前期和衰弱者应加强评估与干预,因其死亡风险均显著升高。

局限性

  • 使用FRAIL量表这一相对较新工具的研究数量尚不多。
  • 仅3项研究提供调整HR进入荟萃分析,证据有限。
  • 作者呼吁需更多研究探讨死亡率及其他健康结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To conduct a systematic review of the literature on prospective cohort studies examining mortality risk according to frailty defined by FRAIL scale, and to perform a meta-analysis to synthesize the pooled risk estimates. DESIGN: Systematic review and meta-analysis. SETTING: Embase, Scopus, MEDLINE, CINAHL, and PsycINFO were systematically searched in March 2018. References of included studies were reviewed and a forward citation tracking was performed on relevant review papers for additional studies. Additional data necessary for a meta-analysis were requested from corresponding authors. PARTICIPANTS: Community-dwelling middle-aged and older adults. MEASUREMENTS: Mortality risk due to frailty as defined by the FRAIL scale. RESULTS: After removing duplicates, there are 81 citations for title, abstract, and full-text screening. Eight studies were included in this review. Four studies calculated the area under the receiver operating characteristic curve, which ranged from 0.54 to 0.70. A random-effects meta-analysis was conducted on 3 studies that provided adjusted hazard ratios (HRs) of mortality risk according to 3 frailty groups (robust, prefrail, and frail) defined by FRAIL scale. Both frailty and prefrailty were significantly associated with higher mortality risk than robustness [pooled HR = 3.53, 95% confidence interval (CI) = 1.66-7.49, P = .001; pooled HR = 1.75, 95% CI = 1.14-2.70, P = .01, respectively]. No evidence of publication bias was observed. CONCLUSION: This study demonstrated that FRAIL scale is a tool that can effectively identify frailty/prefrailty status, as well as quantify frailty status in a graded manner in relation to mortality risk. Although its feasibility is of note, not many studies are yet using this relatively new tool. More studies are warranted regarding mortality and other health outcomes.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Kojima G. Frailty Defined by FRAIL Scale as a Predictor of Mortality: A Systematic Review and Meta-analysis. J Am Med Dir Assoc. 2018. PMID: 29793675. doi:10.1016/j.jamda.2018.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。